Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial

Authors: Jeong Heo, Ja‐Der Liang, Chang Won Kim, Hyun Young Woo, I‐Lun Shih, Tung‐Hung Su, Zhong‐Zhe Lin, So Young Yoo, Stanley Chang, Yasuo Urata, Pei‐Jer Chen - Molecular Therapy 2023 cited by 35